According to FDA labeling, a gradual dose-escalation protocol allows patients to adjust over time, starting at 0.25 mg and increasing to a maintenance dose of 2.4 mg
PlexusDx Personalized Alternatives to Dual-Drug Protocols Rather than combining two separate medications, many patients benefit from PlexusDx compounded therapies designed to maximize single-medication efficacy
In 2022, a phase 3 randomized, controlled clinical trial demonstrated that tirzepatide led to a 20 percent reduction in body weight over 72 weeks
Compounded injections are not FDA-approved as a drug product, but the active pharmaceutical ingredient and preparation methods meet the same safety criteria as brand medications, with the added benefit of dose customization
Host: And when we talk about the reasons someone might be unable to access or use a GLP-1 medication, what would some of those be